Bidirectional regulation of macrophage function by TGF-β

Microbes and Infection

Volumn 1, Issue 15, 1999, Pages 1275-1282

  Ashcroft, Gillian S ^a  

^a Gene Therapy and Therapeutics Branch   (United States)

Author keywords

Bidirectional regulation; Deactivation; Macrophage function; Reactivation; TGF

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; HOST RESISTANCE; HUMAN; IMMUNOREGULATION; INFLAMMATION; MACROPHAGE ACTIVATION; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0033399104     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(99)00257-9     Document Type: Review

References (87)

1. Bogdan C., Nathan C. Modulation of macrophage function by Transforming growth factor β Interleukin-4 and Interleukin-10. Ann. NY Acad. Sci. 1993;713-739.
2. Wahl S.M. Transforming Growth Factor Beta (TGF-β) in Inflammation a cause and a cure. J. Clin. Immunol. 12:1992;61-74.
3. Mc Cartney-Francis N.L., Frazier-Jessen M., Wahl S.M. TGF-β A balancing act. Intern. Rev. Immunol. 16:1998;553-580.
4. Assoian R.K., Fleurdelys B.E., Stevenson H.C., Miller P.J., Madtes D.K., Raines E.W., Ross R., Sporn M.B. Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc. Natl. Acad. Sci. USA. 84:1987;6020-6024.
5. Wahl S.M., Mc Cartney-Francis N., Allen J.B., Dougherty E.B., Dougherty S.F. Macrophage production of TGF-β and regulation by TGF-β Ann. NY Acad. Sci. 593:1990;188-196.
6. Mc Cartney-Francis N., Mizel D., Wong H., Wahl L.M., Wahl S.M. TGF-β regulates production of growth factors and TGF-β by human peripheral blood monocytes. Growth Factors. 4:1990;27-35.
7. Tsunawaki S., Sporn M.B., Ding A., Nathan C. Deactivation of macrophages by transforming growth factor-β Nature. 334:1988;260-262.
8. Massague J. The transforming growth factor-β family. Annu. Rev. Cell Biol. 6:1990;597-641.
9. Letterio J.J., Roberts A.B. Regulation of immune responses by TGF-β Annu. Rev. Immunol. 16:1998;137-161.
10. Mc Cartney-Francis N., Wahl S.M. Transforming growth factor β a matter of life and death. J. Leukoc. Biol. 55:1994;401-409.
11. Wahl S.M. Transforming growth factor beta the good the bad and the ugly. J. Exp. M. 180:1994;1587-1590.
12. Sporn M.B., Roberts A.B. The transforming growth factor-β past present and future. Piez K.A, Sporn M.B. Transforming Growth Factor-β, Chemistry Biology and Therapeutics. 1990;1 New York, New York Academy of Science.
13. Roberts A.B., Sporn M.B. Differential expression of the TGF-beta isoforms in embryogenesis suggests specific roles in developing and adult tissues. Mol. Reprod. Dev. 32:1992;91-98.
14. Assoian R.K., Komoriya A., Meyers C.A., Miller D.M., Sporn M.B. Transforming growth factor beta in human platelets. J. Biol. Chem. 258:1983;7155-7160.
15. Grotendorst G.R., Smale G., Pencev D. Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils. J. Cell Physiol. 140:1989;396-402.
16. Jacobsen S.E.W., Ruscetti F.W., Roberts A.B., Keller J.R. TGF-β is a bidirectional modulator of cytokine receptor expression on murine bone marrow cells Differential effects of TGF-β1 and TGF-β3. J. Immunol. 151:1993;4534-4544.
17. Ashcroft G.S., Dodsworth J., Boxte L.E., Tarnuzzer R., Horan M.A., Schultz G.S., Ferguson M.W.J. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-β1 levels. Nat. M. 3:1997;1209-1215.
18. Wakefield L.M., Smith D.M., Flanders K.C., Sporn M.B. Latent transforming growth factor-β from human platelets, A high molecular weight complex containing precursor sequences. J. Biol. Chem. 263:1988;7646-7654.
19. Grainger D.J., Wakefield L.M., Bethell H.W., Farndale R.W., Metcalf J.C. Release and activation of platelet latent TGF-β in blood clots during dissolution with plasmin. Nat. M. 1:1995;932-937.
20. Schultz-Cherry S., Murphy-Ulrich J.E. Thrombospondin causes activation of latent transforming growth factor-β secreted by endothelial cells by a novel mechanism. J. Cell Biol. 122:1993;923-932.
21. Harpel J.G., Metz C.N., Kojima S., Rifkin D.B. Control of transforming growth factor-beta activity latency vs, activation. Prog. Growth Factor Res. 4:1992;321-335.
22. Barcellos-Hoff M.H., Derynck R., Tsang M.L.S., Weatherbee J.A. Transforming growth factor-β activation in irradiated murine mammary gland. J. Clin. Invest. 93:1994;892-899.
23. Nunes I., Shapiro R.L., Rifkin D.B. Characterization of latent TGF-β activation by murine peritoneal macrophages. J. Immunol. 155:1995;1450-1459.
24. Falcone D.J., Mc Caffrey T., AMathew J., McAdam K., Borth W. THP-1 macrophage membrane-bound plasmin activity is upregulated by transforming growth factor- beta 1 via increased expression of urokinase and the urokinase receptor. J. Cell Physiol. 164:1995;334-343.
25. Twardzik D.R., Mikovits J.A., Ranchalis J.E., Purchio A.F., Ellingsworth L., Ruscetti F.W. γ-Interferon-induced activation of latent transforming growth factor-β by human monocytes. Piez K.A, Sporn M.B. Transforming Growth Factor-β Chemistry Biology and Therapeutics. 1990;276 New York, New York Academy of Science.
26. Salomon G.D., Kasid A., Bernstein E., Buresh C., Director E., Norton J.A. Gene expression in normal and doxorubicin-impaired wounds importance of transforming growth factor-beta. Surgery. 108:1990;318-322.
27. Khalil N., Corne S., Whitman C., Yacyshyn H. Plasmin regulates the activation of cell-associated latent TGF-β1 secreted by alveolar macrophages after in vivo bleomycin injury. Am. J. Resp. Cell Mol. Biol. 15:1996;252-259.
28. Wahl S.M., Allen J.B., Wong H.L., Dougherty S.F., Ellingworth L.R. Antagonistic and agonistic effects of transforming growth factor-β and IL-1 in rheumatoid synovium. J. Immunol. 145:1990;2514-2519.
29. Connor T.B.J.R., Roberts A.B., Sporn M.B., Danielpour D., Dart L.L., Michels R.G., DeBustros S., Enger C., Kato H., Lansing M., Hiyashi H., Glaser B.M. Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J. Clin. Invest. 83:1989;1661-1666.
30. Champsi J., Young L.S., Bermudez L.E. Production of TNF-alpha IL-6 and TGF-β and expression of receptors for TNF-alpha and IL-6 during murine Mycobacterium avium infection. Immunology. 84:1995;549-554.
31. Vodovotz Y., Bogdan C. Control of nitric oxide synthase expression by transforming growth factor-beta implications for homeostasis. Prog. Growth Factor Res. 5:1994;341-351.
32. Barral A., Barral-Netto M., Yong E.C., Brownell C.E., Twardzik D.R., Reed S.G. Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis. Proc. Natl. Acad. Sci. USA. 90:1993;3442-3446.
33. Wrana J.L., Attisano L., Wieser R., Ventura F., Massague J. Mechanism of activation of the TGF-beta receptor. Nature. 370:1994;341-347.
34. Wieser R., Wrana J.L., Massague J. GS domain mutations that constitutively activate TβR-1 the downstream signalling component in the TGF-β receptor complex. EMBO J. 14:1995;2199-2208.
35. Baker J.C., Harland R.M. From receptor to nucleus the Smad pathway. Curr. Opin. Genet. Dev. 7:1997;467-473.
36. Rodriguez C., Chen F., Weinberg R.A., Lodish H.F. Cooperative binding of transforming growth factor (TGF)-β2 to the types I and II TGF-β receptors. J. Biol. Chem. 270:1995;15919-15922.
37. Heldin C.H., Miyazano K., Dijke P. TGF-β signalling from cell membrane to nucleus through Smad proteins. Nature. 390:1997;465-471.
38. Yanagisawa K., Osada H., Masuda A., Kondo M., Saito T., Yasushi Y., Takagi K., Takahashi T., Takahashi T. Induction of apoptosis by Smad3 and downregulation of Smad3 expression in response to TGF-β in human normal lung epithelial cells. Oncogene. 17:1998;1743-1747.
39. Brandes M.E., Wakefield L.M., Wahl S.M. Modulation of monocyte type I TGF-β receptors by inflammatory stimuli. J. Biol. Chem. 266:1991;19697-19703.
40. Wahl S.M., Hunt D.A., Wakefield L., Mc Cartney-Francis N., Wahl L.M., Roberts A.B., Sporn M.B. Transforming growth factor beta (TGF-β) induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. USA. 84:1987;5788-5792.
41. Wiseman D.M., Polverini P.J., Kamp D.W., Leibovich S.J. Transforming growth factor-beta (TGF-β) is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem. Biophys. Res. Commun. 157:1988;793-800.
42. Pierce G.F., Mustoe T.A., Lingelbach J., Masakowski V.R., Gramates P., Deuel T.F. Transforming growth factor β reverses the glucocorticoid-induced wound healing deficit in rats Possible regulation in macrophages by platelet-derived growth factor. Cell Biol. 86:1989;2229-2233.
43. Allen J.B., Manthey C.L., Hand A.R., Ohura K., Ellingsworth L., Wahl S.M. Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta. J. Exp. M. 171:1990;231-247.
44. Luger T.A., Charon J.A., Colot M., Micksche M., Oppenheim J.J. Chemotactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells. J. Immunol. 131:1983;816-821.
45. Ignotz R.A., Heino J., Massague J. Regulation of cell adhesion receptors by transforming growth factor-beta, Concomitant regulation of integrins that share a common beta 1 subunit. J. Biol. Chem. 264:1989;389-392.
46. Wahl S.M., Allen J.B., Weeks B.S., Wong H.L., Klotman P.E. TGF-β enhances integrin expression and Type IV collagenase secretion in human monocytes. Proc. Natl. Acad. Sci. USA. 90:1993;4577-4581.
47. Bauvois B., Rouillard D., Sanceau J., Wietzerbin J. IFN-gamma and transforming growth factor-beta 1 differently regulate fibronectin and laminin receptors of human differentiating monocytic cells. J. Immunol. 148:1992;3912-3919.
48. Bauvois B., VanWeyenbergh J., Rouillard D., Wietzerbin J. TGF-beta 1-stimulated adhesion of human mononuclear phagocytes to fibronectin and laminin is abolished by IFN-gamma dependence on alpha 5 beta 1 and beta 2 integrins. Exp. Cell Res. 222:1996;201-217.
49. Kehrl J.H., Wakefiled L.M., Roberts A.M., Jakowlew S., Alvarez-Mon M., Derynck R., Sporn M.B., Fauci A.S. Production of transforming growth factor-β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. M. 163:1986;1037-1050.
50. Turner M., Chantry D., Feldmann M. Transforming growth factor β induces the production of interleukin 6 by human peripheral blood mononuclear cells. Cytokine. 2:1990;211-216.
51. Kulkarni A.B., Huh C., Becker D., Geiser A., Lyght M., Flanders K.C., Roberts A.B., Sporn M.B., Ward J.M., Karlsson S. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA. 90:1993;770-774.
52. Kulkarni A.B., Ward J.M., Geiser A.G., Letterio J.J., Hines K.L., Christ M., D'Souza R.N., Huh C., Roberts A.B., Sporn M.B., Mc Cartney-Francis N., Wahl S.M., Glick A.B., Yuspa S.H., Mackall C., Gress R.E., Karlsson S. TGF-β1 knockout mice immune dysregulation and pathology. Graham N.G, Shadduck R.K, Levin A.S, Takaku F. Molecular Biology of Haematopoiesis. 1994;749-757 Intecept, Paris.
53. Welch G.R., Wong H.L., Wahl S.M. Selective induction of Fc gamma RIII on human monocytes by transforming growth factor-beta. J. Immunol. 144:1990;3444-3448.
54. Phillips J.H., Chang C.W., Lanier L.L. Platelet-induced expression of Fc gamma RIII (CD16) on human monocytes. Eur. J. Immunol. 4:1991;895-899.
55. Hogasen A.K., Hestdal K., Hogasen K., Abrahamsen T.G. Transforming growth factor beta modulates C3 and factor B biosynthesis and complement receptor 3 expression in cultured human monocytes. J. Leukoc. Biol. 57:1995;287-296.
56. Kruger M., Coorevits L., De Wit T.P., Casteels-Van Daele M., Van DeWinkel J.G., Ceuppens J.L. Granulocyte-macrophage colony-stimulating factor antagonizes the transforming growth factor-beta-induced expression of Fc gamma RIII (CD16) on human monocytes. Immunology. 87:1996;162-167.
57. Shah M., Foreman D.M., Ferguson M.W.J. Control of scarring in adult wounds by neutralising antibodies to transforming growth factor beta. Lancet. 339:1992;213-214.
58. Border W.A., Noble N.A., Yamamoto T., Harper J.R., Yamaguchi Y., Pierschbacher M.D., Ruoslahti E. Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature. 360:1992;361-364.
59. Isaka Y., Brees D.K., Ikegaya K., Kaneda Y., Imai E., Noble N.A., Border W.A. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat. M. 2:1996;418-423.
60. Shah M., Foreman D.M., Ferguson M.W.J. Neutralizing antibody to TGF-β1,2 reduces cutaneous scarring in adult rodents. J. Cell Sci. 107:1994;1137-1157.
61. Whitby D.J., Ferguson M.W.J. Immunohistochemical localization of growth factors in fetal wound healing. Dev. Biol. 147:1991;207-215.
62. Adzick N.S., Lorenz H.P. Cells matrix growth factors and the surgeon, The biology of scarless fetal wound repair. Ann. Surg. 220:1994;10-18.
63. Cowin A.J., Brosnan M.P., Holmes T.M., Ferguson M.W.J. Endogenous inflammatory response to dermal wound healing in the fetal and adult mouse. Dev. Dyn. 212:1998;385-393.
64. Frank S., Madlener M., Werner S. Transforming growth factors β1, β2, and β3 and their receptors are differentially regulated during normal and impaired wound healing. J. Biol. Chem. 271:1996;10188-10193.
65. Kopp J.B., Factor V.M., Mozes M., Nagy P., Sanderson N., Bottinger E.P., Klotman P.E., Thorgeirsson S.S. Transgenic mice with increased plasma levels of TGF-β1 develop progressive renal disease. Lab. Invest. 74:1996;991-1003.
66. Letterio J.J., Roberts A.B. Transforming growth factor-β1-deficient mice identification of isoform-specific activities in vivo. J. Leuk. Biol. 59:1996;769-774.
67. Gamble J.R., Khew-Goodall Y., Vadas M.A. Transforming growth factor-β inhibits E-selectin expression on human endothelial cells. J. Immunol. 150:1993;4494-4503.
68. Lefer A.M., Ma X.L., Weyrich A.S., Scalia R. Mechanism of the cardioprotective effect of transforming growth factor β1 in feline myocardial ischemia and reperfusion. Proc. Natl. Acad. Sci. USA. 90:1993;1018-1022.
69. Hines K.L., Kulkarni A.B., Mc Carthy J.B., Tian H., Ward J.M., Christ M., McCartney-Francis N., Furcht L.T., Karlsson S., Wahl S.M. Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor β1 knockout mice. Proc. Natl. Acad. Sci. USA. 91:1994;5187-5191.
70. Mc Cartney-Francis N., Mizel D., Redman R.S., Frazier-Jessen M., Panek R.B., Kulkarni A.B., Ward J.M., McCarthy J.B., Wahl S.M. Autoimmune Sjogren's-like lesions in salivary glands of TGF-β1-deficient mice are inhibited by adhesion-blocking peptides. J. Immunol. 157:1996;1306-1312.
71. Diebold R.J., Eis M.J., Yin M., Ormsby I., Boivin G.P., Darrow B.J., Saffitz J.E., Doetschman T. Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated. Proc. Natl. Acad. Sci.USA. 92:1995;12215-12219.
72. Kitamura M. Identification of an inhibitor targeting macrophage production of monocyte chemoattractant protein-1 as TGF-β1. J. Immunol. 159:1997;1404-1411.
73. Sherry B., Espinoza M., Manogue K.R., Cerami A. Induction of the chemokine β peptides MIP-1α and MIP-1β by lipopolysaccharide is differentially regulated by immunomodulatory cytokines γ-IFN, IL-10, IL-4 and TGF-β Mol. M. 4:1998;648-657.
74. Fadok V.A., Bratton D.L., Konowai A., Freed P.W., Westcott J.Y., Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J. Clin. Invest. 101:1998;890-898.
75. Tracey K.J., Wei H., Manogue K.R., Fong Y., Hesse D.G., Nguyen H.T., Kuo G.C., Beutler B., Cotran R.S., Cerami A., Lowry S.F. Cachectin/tumor necrosis factor induces cachexia anemia and inflammation. J. Exp. M. 167:1988;1211-1227.
76. Turner M., Chantry D., Katsikis P., Berger A., Brennan F.M., Feldmann M. Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-beta. Eur. J. Immunol. 21:1991;1635-1639.
77. Wahl S.M., Costa G.L., Corcoran M., Wahl L.M., Berger A.E.,). Transforming growth factor-β mediates IL-1-dependent induction of IL-1 receptor antagonist. J. Immunol. 150:1993b;3553-3560.
78. Ohguchi M., Yamato K., Ishihara Y., Koide M., Ueda N., Okahashi N., Noguchi T., Kizaki M., Ikeda Y., Sugino H., Nishihara T. Activin A regulates the production of mature interleukin-1β and interleukin-1 receptor antagonist in human monocytic cells. J. Interferon Cytokine Res. 18:1998;491-498.
79. Leveque C., Grafte S., Paysant J., Soutif A., Lenormand B., Vasse M., Soria C., Vannier J.P. Regulation of interleukin 3 receptor a chain (IL-3Ra) on human monocytes by interleukin (IL)-4 IL-10 IL-13 and transforming growth factor β (TGF-β Cytokine. 10:1998;487-494.
80. Warwick-Davies J., Lowrie D.B., Cole P.J. Selective deactivation of human monocyte functions by TGF-β J. Immunol. 155:1995;3186-3193.
81. Vodovotz Y., Geiser A.G., Chesler L., Letterio J.J., Campbell A., Lucia M.S., Sporn M.B., Roberts A.B. Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor β1 null mouse. J. Exp. M. 183:1996;2337-2342.
82. Erwig L.P., Kluth D.C., Walsh G.M., Rees A.J. Initial cytokine exposure determines function of macrophages and renders them unresponsive to other cytokines. J. Immunol. 161:1998;1983-1988.
83. Brandes M.E., Allen J.B., Ogawa Y., Wahl S.M. Transforming growth factor β1 suppresses acute and chronic arthritis in experimental animals. J. Clin. Invest. 87:1991;1108-1113.
84. Song X.Y., Jin W.W., Klinman D.M., Wahl S.M. Plasmid DNA encoding transforming growth factor-beta 1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model. J. Clin. Invest. 101:1998;2615-2621.
85. Kuruvilla A.P., Shah R., Hochwald G.M., Liggitt H.D., Palladino M.A., Thorbecke G.J. Protective effects of transforming growth factor β1 on experimental autoimmune disease in mice. Proc. Natl. Acad. Sci. USA. 88:1991;2918-2921.
86. Racke M.K., Dhib-Jalbu S., Cannella B., Albert P.S., Raine C.S., McFarlin D.E. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β J. Immunol. 146:1991;1792-1796.
87. Border W.A., Okuda S., Languino L.R., Sporn M.B., Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature. 360:1990;361-364.